News from viiv healthcare A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 08, 2012, 03:30 ET

ViiV Healthcare commits nearly £4M in Positive Action for Children Fund grants for programmes focused on alleviating burden of HIV on women and children

ViiV Healthcare announced today that it has awarded nearly £4 million to 99 projects in 26 countries through its Positive Action for Children...

Jul 26, 2012, 16:30 ET

Once-Daily Dolutegravir is Non-Inferior to Twice-Daily Raltegravir in Treatment-Naive Adults with HIV-1

Shionogi-ViiV Healthcare LLC today announced 48-week data from the SPRING-2 Phase III study, which is evaluating the investigational integrase...

Jul 18, 2012, 04:00 ET

ViiV Healthcare Expands Commitment to Addressing Gaps in Paediatric HIV Research, Care and Treatment

ViiV Healthcare today announced a broad range of groundbreaking initiatives as part of its ongoing commitment to address the gaps in care and...

Jul 11, 2012, 02:08 ET

Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV

Shionogi-ViiV Healthcare LLC today announced that initial results have been received from the Phase III SINGLE (ING114467) study of the...

Apr 02, 2012, 02:09 ET

Shionogi-ViiV Healthcare Announces Initial Data from Pivotal Phase III Study of Dolutegravir in HIV

 ViiV Healthcare and Shionogi & Co., Ltd. today announced that initial results have been received from the SPRING-2 (ING113086) Phase III...

Oct 13, 2011, 09:00 ET

ViiV Healthcare's Positive Action for Children Fund Announces 16 New Grantees for the Year 2011/2012

ViiV Healthcare announced today that it has awarded approximately 3.9 million pounds Sterling to 16 organisations in eight countries, through its...

Oct 12, 2011, 19:07 ET

'ViiV Healthcare Effect' haucht den positiven Aktionspartnerschaften von ViiV Healthcare Leben ein

- Persönliche Geschichten, Lebenserfahrungen und Kooperationen auf neuer Website vorgestellt WAS: Der ViiV Healthcare Effect...

Oct 12, 2011, 18:55 ET

'ViiV Healthcare Effect' proporciona asociaciones de acción positivas para la vida de ViiV Healthcare

- La nueva página web muestra las historias personales, experiencias de la vida real y colaboraciones QUÉ: ViiV Healthcare...

Oct 12, 2011, 13:58 ET

"ViiV Healthcare Effect"dá vida a parcerias da Ação Positiva da ViiV Healthcare

O QUE: O ViiV Healthcare Effect (www.ViiVHealthcareEffect.com) apresenta a abordagem de nossa empresa a parcerias, de uma forma única e...

Oct 12, 2011, 13:47 ET

'ViiV Healthcare Effect' donne vie aux partenariats Action positive de ViiV Healthcare

  - Un nouveau site Web présente des histoires personnelles, des expériences dans la vraie vie et des collaborations SUJET :...

Oct 12, 2011, 05:00 ET

'ViiV Healthcare Effect' hace realidad las asociaciones para la acción positiva de ViiV Healthcare

QUÉ: ViiV Healthcare Effect (www.ViiVHealthcareEffect.com) presenta el enfoque de nuestra compañía a las asociaciones de un...

Oct 12, 2011, 05:00 ET

'ViiV Healthcare Effect' Brings ViiV Healthcare's Positive Action Partnerships to Life

WHAT: The ViiV Healthcare Effect (www.ViiVHealthcareEffect.com) introduces our company's approach to partnerships in a unique and personal way....

Oct 11, 2011, 09:00 ET

ViiV Healthcare Starts Phase III Clinical Programme of Celsentri/Selzentry® (maraviroc) versus Truvada® (tenofovir + FTC), in combination with a Protease Inhibitor in people living with HIV

ViiV Healthcare announces the start of the Phase III MODERN Study [Maraviroc Once daily with Darunavir Enhanced by Ritonavir in a Novel regimen],...

Feb 03, 2011, 03:00 ET

Shionogi-ViiV Healthcare Starts Phase III Trial for '572-Trii' Fixed-Dose Combination HIV Therapy

Shionogi-ViiV Healthcare, LLC announced today that the first patient has entered the clinical study, SINGLE (ING114467), designed to support a new...

Oct 21, 2010, 04:00 ET

Shionogi-ViiV Healthcare LLC Initiates Phase III Clinical Programme for Investigational Once-Daily HIV Integrase Inhibitor

Shionogi-ViiV Healthcare LLC today announced the start of the Phase III clinical programme evaluating its once-daily, unboosted investigational...

Oct 12, 2010, 09:00 ET

ViiV Healthcare Acts to Improve Access to HIV Medicines in United States for Those Most in Need

ViiV Healthcare will expand its Patient Assistance Program effective January 1, 2011 and continue its Patient Savings Card program to help maintain...

Sep 09, 2010, 10:00 ET

ViiV Healthcare Awards Southern Initiative Grants to Reduce HIV Disparities Among African Americans and Latinos

ViiV Healthcare today announced the grant awardees of the Positive Action Southern Initiative, focused on supporting African American and Latino...

Jul 22, 2010, 08:30 ET

Shionogi-ViiV Healthcare LLC Presents Positive Data on Investigational Once-Daily Integrase Inhibitor at International AIDS Conference

Shionogi-ViiV Healthcare LLC today reported data from two Phase IIb studies showing that its once-daily, unboosted investigational integrase...

Jul 21, 2010, 04:00 ET

Shionogi-ViiV Healthcare Announces Commitment to Phase III Development Program for Investigational Once-Daily HIV Integrase Inhibitor

Shionogi-ViiV Healthcare LLC today announced that it will be progressing its once-daily, unboosted investigational integrase inhibitor,...

Jul 06, 2010, 14:43 ET

ViiV Healthcare Announces Positive Action U.S. Southern Initiative, an Innovative Community Support Program to Fight HIV/AIDS

ViiV Healthcare today announced the launch of Positive Action U.S. Southern Initiative, a collaborative, community-focused program designed to...